Leap Therapeutics
LPTX
LPTX
48 hedge funds and large institutions have $37.8M invested in Leap Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.05% less ownership
Funds ownership: 38.51% → 38.46% (-0.05%)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Holders
48
Holding in Top 10
–
Calls
$23K
Puts
$11K
Top Buyers
| 1 | +$1.09M | |
| 2 | +$264K | |
| 3 | +$207K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$139K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$129K |
Top Sellers
| 1 | -$1.17M | |
| 2 | -$223K | |
| 3 | -$191K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$187K |
| 5 |
Renaissance Technologies
New York
|
-$149K |